Annual Short Term Debt
$4.91 M
+$476.00 K+10.74%
December 31, 2023
Summary
- As of February 12, 2025, TVTX annual short term debt is $4.91 million, with the most recent change of +$476.00 thousand (+10.74%) on December 31, 2023.
- During the last 3 years, TVTX annual short term debt has risen by +$4.55 million (+1275.07%).
- TVTX annual short term debt is now -87.87% below its all-time high of $40.49 million, reached on December 31, 2014.
Performance
TVTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$73.90 M
+$68.73 M+1331.26%
September 30, 2024
Summary
- As of February 12, 2025, TVTX quarterly short term debt is $73.90 million, with the most recent change of +$68.73 million (+1331.26%) on September 30, 2024.
- Over the past year, TVTX quarterly short term debt has increased by +$68.99 million (+1405.32%).
- TVTX quarterly short term debt is now at all-time high.
Performance
TVTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TVTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | +1405.3% |
| 3 y3 years | +1275.1% | +1567.0% |
| 5 y5 years | -78.1% | +1567.0% |
TVTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.6% | at high | +1790.9% |
| 5 y | 5-year | at high | +1275.1% | at high | >+9999.0% |
| alltime | all time | -87.9% | >+9999.0% | at high | -100.0% |
Travere Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $73.90 M(+1331.3%) |
| Jun 2024 | - | $5.16 M(+2.5%) |
| Mar 2024 | - | $5.04 M(+2.6%) |
| Dec 2023 | $4.91 M(+10.7%) | $4.91 M(+2.7%) |
| Sep 2023 | - | $4.78 M(+2.6%) |
| Jun 2023 | - | $4.66 M(+2.6%) |
| Mar 2023 | - | $4.54 M(+2.5%) |
| Dec 2022 | $4.43 M(+13.4%) | $4.43 M(+4.7%) |
| Sep 2022 | - | $4.23 M(+2.7%) |
| Jun 2022 | - | $4.12 M(+2.7%) |
| Mar 2022 | - | $4.01 M(+2.7%) |
| Dec 2021 | $3.91 M(+994.7%) | $3.91 M(+994.7%) |
| Dec 2020 | $357.00 K(-98.4%) | $357.00 K(-98.4%) |
| Mar 2019 | - | $22.54 M(+0.4%) |
| Dec 2018 | $22.46 M | $22.46 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $22.38 M(-50.7%) |
| Jun 2018 | - | $45.40 M(>+9900.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $41.13 M(>+9900.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | $40.49 M(+4475.7%) | $40.49 M(+29.4%) |
| Mar 2014 | - | $31.28 M(>+9900.0%) |
| Dec 2012 | $884.80 K(+3439.2%) | - |
| Nov 2012 | - | $25.00 K(0.0%) |
| Aug 2012 | - | $25.00 K(0.0%) |
| May 2012 | - | $25.00 K(0.0%) |
| Feb 2012 | - | $25.00 K(0.0%) |
| Feb 2012 | $25.00 K(0.0%) | - |
| Nov 2011 | - | $25.00 K(0.0%) |
| Feb 2011 | $25.00 K | $25.00 K |
FAQ
- What is Travere Therapeutics annual short term debt?
- What is the all time high annual short term debt for Travere Therapeutics?
- What is Travere Therapeutics annual short term debt year-on-year change?
- What is Travere Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Travere Therapeutics?
- What is Travere Therapeutics quarterly short term debt year-on-year change?
What is Travere Therapeutics annual short term debt?
The current annual short term debt of TVTX is $4.91 M
What is the all time high annual short term debt for Travere Therapeutics?
Travere Therapeutics all-time high annual short term debt is $40.49 M
What is Travere Therapeutics annual short term debt year-on-year change?
Over the past year, TVTX annual short term debt has changed by +$476.00 K (+10.74%)
What is Travere Therapeutics quarterly short term debt?
The current quarterly short term debt of TVTX is $73.90 M
What is the all time high quarterly short term debt for Travere Therapeutics?
Travere Therapeutics all-time high quarterly short term debt is $73.90 M
What is Travere Therapeutics quarterly short term debt year-on-year change?
Over the past year, TVTX quarterly short term debt has changed by +$68.99 M (+1405.32%)